Total neoadjuvant therapy with split-course hypofraction radiotherapy combined with CAPOX and envafolimab followed by local excision for locally advanced very low rectal cancer (TRACE-LE): An open-label, single-arm, multicenter, phase II trial

被引：0
|
作者：
Jiang, Weizhong
Chi, Pan
Tao, Kaixiong
Xu, Dongbo
Yang, Chunkang
Zheng, Rong
Xu, Benhua
Huang, Ying
Chen, Zhifen
Huang, Shenghui
Xu, Zongbin
机构：
[1] Fujian Med Univ, Dept Colorectal Surg, Union Hosp, Fuzhou, Fujian, Peoples R China
[2] Huazhong Univ Sci & Technol, Union Hosp, Med Coll, Wuhan, Peoples R China
[3] Fujian Med Univ, Longyan Affiliated Hosp, Longyan, Peoples R China
[4] Fujian Prov Canc Hosp, Fuzhou, Peoples R China
[5] Fujian Med Univ, Dept Radiat Oncol, Union Hosp, Fuzhou, Fujian, Peoples R China
[6] Fujian Med Univ, Dept Colorectal Surg, Union Hosp, Fuzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS3647
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Upfront radical surgery with total mesorectal excision followed by adjuvant FOLFOX chemotherapy for locally advanced rectal cancer (TME-FOLFOX): an open-label, multicenter, phase II randomized controlled trial
    Jii Bum Lee
    Han Sang Kim
    Inkyung Jung
    Sang Joon Shin
    Seung Hoon Beom
    Jee Suk Chang
    Woong Sub Koom
    Tae Il Kim
    Hyuk Hur
    Byung Soh Min
    Nam Kyu Kim
    Sohee Park
    Seung-Yong Jeong
    Jeong-Heum Baek
    Seon Hahn Kim
    Joon Seok Lim
    Kang Young Lee
    Joong Bae Ahn
    Trials, 21
  • [32] Short-Course Radiotherapy Based Total Neoadjuvant Therapy Combined with Toripalimab for Locally Advanced Rectal Cancer: Preliminary Findings from a Randomized, Prospective, Multicenter, Double-Arm, Phase II Trial (TORCH)
    Wang, Y.
    Xia, F.
    Shen, L.
    Wan, J.
    Zhang, H.
    Wu, R.
    Wang, J.
    Wang, Y.
    Xu, Y.
    Cai, S.
    Zhang, Z.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E152 - E152
  • [33] An Open-Label, Phase II, Multicenter, Single-Arm Study of Induction and Concurrent Vismodegib Combined with Curative-Intent Radiation Therapy for Locally Advanced Basal Cell Carcinoma
    Yom, Sue
    Arron, Sarah
    Ho, Alan
    Algazi, Alain
    Dunn, Lara
    Tsai, C. Jillian
    Humphries, Audrey
    Hultman, Carter
    Grekin, Roy
    Knott, P. Daniel
    Barker, Christopher
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2021, 44 (10): : S16 - S16
  • [34] Phase II, single-arm trial of preoperative short-course radiotherapy followed by chemotherapy and camrelizumab in locally advanced rectal cancer (vol 9, e003554, 2021)
    Lin, Z.
    Cai, M.
    Zhang, P.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (02)
  • [35] Total neoadjuvant treatment with long-course radiotherapy versus concurrent chemoradiotherapy in local advanced rectal cancer with high risk factors (TNTCRT): A multicenter, randomized, open-label, phase 3 trial.
    Wang, Xin
    Liu, Ping
    Xiao, Yi
    Meng, Wenjian
    Tang, Yuanling
    Zhou, Jitao
    Ding, Pei-Rong
    Ding, Ke-Feng
    Wang, Biao
    Guo, Qing
    Sun, Hao
    Qiu, Jian
    Yu, Yongyang
    Wu, Bing
    Zeng, Hanjiang
    Deng, Xiang-bing
    Jiang, Dan
    Shen, Ya-li
    Zhou, Zongguang
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (17_SUPPL) : LBA3511 - LBA3511
  • [36] Nimotuzumab plus induction chemotherapy followed by radiotherapy/concurrent chemoradiotherapy plus nimotuzumab for locally advanced nasopharyngeal carcinoma: protocol of a multicentre, open-label, single-arm, prospective phase II trial
    Yuan, Jing-Jing
    Ding, Jian-Wu
    Li, Jin-Wei
    Hu, Rong-Huan
    Gong, Dan
    Hu, Jia-Li
    Zhu, Kai-Bin
    Liu, Yan
    Ding, Yu-Hai
    Wei, Jia-Wang
    Zeng, Jian-Lun
    Lu, Zhi-Bing
    Yin, Wei-Hua
    Ai, Su-Fen
    Zha, Guo-Hua
    Zhang, Zhi-Lin
    Zou, Rui
    Zeng, Lei
    BMJ OPEN, 2022, 12 (08):
  • [37] Preliminary efficacy and safety of total neoadjuvant therapy combined with PD-L1 blockade in pMMR/MSS locally advanced rectal cancer (ESTIMATE): A prospective, single-arm, phase II trial
    Zhang, Xuan, Sr.
    Feng, Qing, Jr.
    Cai, Xinyi, Sr.
    Yu, Kun, Sr.
    Shen, Tao, Sr.
    Pan, Dingguo, Sr.
    Tan, Jing, Sr.
    Ju, Yunhe, Sr.
    Zhang, Lijuan, Sr.
    Xie, Lin, Sr.
    Dong, Jianhua, Sr.
    Xia, Cuifeng, Sr.
    Xiong, Wei, Sr.
    Yang, Quan, Jr.
    Wu, Tao, Jr.
    Li, Yun-Feng, Sr.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [38] Pathological response and safety of FOLFOXIRI for neoadjuvant treatment of high-risk relapsed locally advanced colon cancer: study protocol for a single-arm, open-label phase II trial
    Chen, Xiaorong
    Leng, Weibing
    Zhou, YuWen
    Yu, Yongyang
    Meng, Wenjian
    Cao, Peng
    Wang, Ziqiang
    Qiu, Meng
    BMJ OPEN, 2023, 13 (01):
  • [39] Comprehensive multi-omics analysis of resectable locally advanced gastric cancer: Assessing response to neoadjuvant camrelizumab and chemotherapy in a single-center, open-label, single-arm phase II trial
    Zhao, Yuzhou
    Li, Danyang
    Zhuang, Jing
    Li, Zhimeng
    Xia, Qingxin
    Li, Zhi
    Yu, Juan
    Wang, Jinbang
    Zhang, Yong
    Li, Ke
    Xu, Shuning
    Li, Sen
    Ma, Pengfei
    Cao, Yanghui
    Liu, Chenyu
    Xu, Chunmiao
    Liu, Zhentian
    Wei, Jinwang
    Zhang, Chengjuan
    Qiao, Lei
    Gao, Xuan
    Hou, Zhiguo
    Liu, Chenxuan
    Zheng, Rongrong
    Wang, Du
    Liu, Ying
    CLINICAL AND TRANSLATIONAL MEDICINE, 2024, 14 (05):
  • [40] Phase II, single-arm, open-label study of dostarlimab monotherapy in previously untreated patients with stage II/III dMMR/MSI-H locally advanced rectal cancer: trial in progress
    Cercek, Andrea
    Bachet, Jean-Baptiste
    Capdevilla, Jaume
    Starling, Naureen
    Chen, Eric
    Di Bartolomeo, Maria
    Yoshino, Takayuki
    Vlahovic, Gordana
    Zografos, Eleftherios
    O'donnell, Sean
    Szijgyarto, Zsolt
    Heinemann, Volker
    ONCOLOGY RESEARCH AND TREATMENT, 2024, 47 : 59 - 59
12345